ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,751, issued on June 10, was assigned to Shandong Boan Biotechnology Co. Ltd. (Yantai, China).

"Anti-CD25 antibody and application thereof" was invented by Deyong Song (Shandong, China), Xiu Liu (Shandong, China) and Jing Han (Shandong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides an antibody binding to CD25 or an antigen-binding fragment thereof and a use thereof for the preparation of a therapeutic cancer drug. The antibody or antigen-binding fragment thereof comprises a light chain variable region and a heavy chain variable region containing a specific complementarity-determining region sequence. The antibody...